Get started
TELADOCHEALTDRNTELADOCHEALTDRNTELADOCHEALTDRN

TELADOCHEALTDRN

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals Bonds

T2DH34 trade ideas

TDOC : POSITION TRADE / RESETTeladoc is the sixth-largest holding in the ARKK ETF - a top performing actively managed fund focused on disruptive innovations. Teladoc reported third-quarter revenue up 109% year-over-year to $288.8 million. Total visits increased 206% year-over-year to 2.8 million. The company expects to end the year with 50 million to 51 million U.S. paid members and 21 million to 22 million visit fee only members. The Teladoc - Livongo merger has created the singular global, consumer-centered virtual care platform. Together, they have formed the dominant category leader with a massive $121 billion Total Addressable Market. seekingalpha.com
NYSE:TDOCLong
by TradingMavericks
Trading Idea - #TeladocSHORT against Cathie Wood! Time is too young for this innovation! :-) ENTRY: 152.20 USD TARGET1: 86.30 USD TARGET2: 58.90 USD (+61%) STOP: 208.30 USD Teladoc Health provides virtual healthcare services on a business-to-business (B2B) basis to its clients and provides services to consumers directly and through channel partners. The Company's consumer brands, including Teladoc, Advance Medical, Best Doctors, BetterHelp and HealthiestYou, provides access to advice and resolution to a range of healthcare needs. Its technology enables consumers to manage their own electronic medical records. It also provides access to a message center, provider finder, image upload capability and enable real-time sharing capabilities with providers that includes visit scheduling. Number of employees : 4 400 people. 1.) Teladoc broke through the short-term support area easily! Usual indicator to continue downward trend! 2.) Q1 Net Loss Expands as Sales Advance 3.) The largest stake in the Ark Genomic Revolution ETF is Teladoc Health. The company is the most heavily weighted stock in the fund at 7.44%. Teladoc rose to a record high earlier this year and has since fallen 34%.
NYSE:TDOCShort
by Traderherz-Analytics
5
TDOC - INVESTMENT TRADEA great strategy for long term investment is to find a company that 1. everyone uses, 2. is not going out of business and 3. at a depressed price hitting a long term moving average on the weekly or monthly.. This company checks all 3 of my criteria. I love buying here off the weekly 100MA and if it drops more I'll buy again at the monthly 50EMA. You can't predict the bottom but you can find nice entry points. Great long term buy and hold, either through long dated options or shares outright.
NYSE:TDOCLong
by carley621
1
TDOC waiting at 500 MASo TDOC has hit close to my 140s target by May earnings. But, I wasn't very happy about the way the right shoulder got formed. It just wasn't convincing enough. I now consider the idea of TDOC sitting at the 500 Day Moving Average. The last time TDOC re tested the 500MA was in December 2018, after which we saw a 65% jump. If a similar pattern follows, I think TDOC could be re testing close to 240$ again before next earnings. This would also complete the right shoulder. I would just watch carefully for wider market pressure in the late May to early July period. Good luck!
NYSE:TDOC
by Karam08
1
$TDOC Support Play?Looks like $TDOC may have found some support around the $170 area. I opened a small starter position this morning to try and play that bounce. This is a high risk trade as it's below ALL moving averages. Do your own due diligence. I like the name and what they do. They beat on earnings and guided slightly higher but got beat down, guidance not high enough? Ideas, not investing / trading advice. from earningswhispers.com: Teladoc Health Beats Teladoc Health (TDOC) reported 1st Quarter March 2021 earnings of $0.13 per share on revenue of $453.7 million. The consensus estimate was a loss of $0.57 per share on revenue of $451.9 million. The Earnings Whisper number was for a loss of $0.66 per share. Revenue grew 150.9% on a year-over-year basis. The company said it expects second quarter revenue of $495.0 million to $505.0 million and 2021 revenue of $1.97 billion to $2.02 billion. the company's previous guidance was 2021 revenue of $1.95 billion to $2.00 billion. The current consensus revenue estimate is $486.39 million for the quarter ending June 30, 2021 and revenue of $1.99 billion for the year ending December 31, 2021. Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey.
NYSE:TDOCLong
by jaxdog
TDOC Big move coming going into EarningsTDOC looking good for a long setup going into earnings. ER is on 5/4. TDOC has been beaten down the past earnings but technicals are showing upside potential. We also have gaps above. Looking for a break through that 213 level (200 SMA) and push through earnings. Setups: Squeezing on the daily timeframe and we're on the 4th wave of the wolf wave pattern. Contract Suggestion: Spreads are really nasty, this is the only option chain date that I found fairly decent. TDOC 5/21 240C @ 1.75 (Long swings -safer play)
NYSE:TDOCLong
by Ross-Santos
TDOC Inverse Head and Shoulders Long StrategyAfter being beaten down during the Feb-Mar correction, TDOC is sitting more than 100 points below its ATH. It is awfully close to the neckline which happens to coincide with the 50 day SMA @ around 187. Also note the massive gap above the neckline indicated by the grey rectangle -- around 12 points. This looks to be a very rewarding long strategy and even a good buy for shares given the upside potential and increased relevance of telehealth.
NYSE:TDOCLong
by TheTraderMoes
3
TDOC to $140s by May earnings?I'm in TDOC, it has delivered more than I have expected, specially that December to Feb run we enjoyed. Fundamentals But, as much as I believe in the long term potential of TDOC, I don't think enough people know where the growth potential in the company comes from. This isn't just a telemedicine covid stock that many people think. This company has a vision that is prepared to make the most out of the slightest of weakness in the nation's healthcare system. If you believe the traditional US healthcare sector is going to become super efficient in the next 5 years, don't invest in TDOC. But my bet is that the only way the US will be able to better manage the healthcare needs of such a vast population is through innovations across disruptive platforms like Teladoc. Some of TDOC's acquisitions in recent years that expand their offering: livongo, inTouch health, Best Doctors, Advance medical. Technical analysis RSI is currently oversold. Broadly the market is recovering, as will Tdoc, but with a weaker earnings report in Feb, the pressure will be on during the May earnings. If TDOC does a clean break upward of 230$, we're good. But, I believe, similar to the June 2020 - Jan 2021 run, TDOC will run through a flat out consolidation between the $185 - $235 range , shortly after which a Head and Shoulder pattern may be obvious. Given the broader market risks mid year and May being earnings, I expect the drop to $140 may happen around then. If we continue to consolidate, I will still keep an eye out as I believe TDOC will find a deeper correction (and a better buying opportunity) in 2021. Good luck traders!
NYSE:TDOCLong
by Karam08
1